Citadel Advisors’s Semler Scientific SMLR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-145,208
| Closed | -$2.22M | – | 14135 |
|
|
2025
Q4 | $2.22M | Sell |
145,208
-258,067
| -64% | -$5.85M | ﹤0.01% | 5714 |
|
|
2025
Q3 | $12.1M | Sell |
403,275
-214,022
| -35% | -$7.36M | ﹤0.01% | 2979 |
|
|
2025
Q2 | $23.9M | Buy |
617,297
+602,418
| +4,049% | +$21.5M | ﹤0.01% | 1939 |
|
|
2025
Q1 | $539K | Buy |
14,879
+3,748
| +34% | +$176K | ﹤0.01% | 8310 |
|
|
2024
Q4 | $601K | Sell |
11,131
-9,727
| -47% | -$447K | ﹤0.01% | 8156 |
|
|
2024
Q3 | $491K | Buy |
+20,858
| New | +$599K | ﹤0.01% | 8292 |
|
|
2024
Q2 | – | Sell |
-31,915
| Closed | -$932K | – | 15303 |
|
|
2024
Q1 | $932K | Buy |
+31,915
| New | +$1.33M | ﹤0.01% | 7069 |
|
|
2023
Q4 | – | Sell |
-13,029
| Closed | -$331K | – | 15171 |
|
|
2023
Q3 | $331K | Sell |
13,029
-14,151
| -52% | -$368K | ﹤0.01% | 8972 |
|
|
2023
Q2 | $713K | Sell |
27,180
-11,759
| -30% | -$310K | ﹤0.01% | 7153 |
|
|
2023
Q1 | $1.04M | Buy |
+38,939
| New | +$1.09M | ﹤0.01% | 6691 |
|
|
2022
Q4 | – | Sell |
-22,154
| Closed | -$832K | – | 15412 |
|
|
2022
Q3 | $832K | Buy |
+22,154
| New | +$836K | ﹤0.01% | 7394 |
|
|
2022
Q2 | – | Sell |
-33,943
| Closed | -$1.68M | – | 14017 |
|
|
2022
Q1 | $1.68M | Buy |
33,943
+16,233
| +92% | +$1.09M | ﹤0.01% | 6479 |
|
|
2021
Q4 | $1.62M | Buy |
+17,710
| New | +$1.98M | ﹤0.01% | 6716 |
|
Citadel Advisors's SMLR Position: Q1 2026 in Review
Citadel Advisors sold out of Semler Scientific (SMLR) in Q1 2026, closing a stake of 145,208 shares — an estimated $2.22M sold.
Citadel Advisors first reported a position in SMLR in Q4 2021 and held it in 13 quarters. The position peaked at $23.9M in Q2 2025. 0 funds tracked by Wall St. Rank hold SMLR as of Q1 2026.
- Citadel Advisors reported no remaining Semler Scientific position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 145,208 Semler Scientific shares in Q1 2026, an estimated $2.22M.
- Citadel Advisors first reported a position in Semler Scientific in Q4 2021 and held it in 13 quarters.
- Citadel Advisors's Semler Scientific position peaked at $23.9M in Q2 2025.
- 0 funds tracked by Wall St. Rank held Semler Scientific as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.